Imbed Biosciences

Imbed Biosciences, Inc. is a private medical device company at the forefront of developing advanced therapies for burns, chronic ulcers, gastrointestinal defects, and soft tissue repair. The company has a portfolio of products in development based on its patented MicroLyte® Matrix technology, which presents bioactive molecules on tissue surfaces to combat local pain and infection. The micron-scale matrix accelerates cell migration and reduces antibiotic/opioid abuse. The company is registered with the U.S. FDA as a medical device manufacturer and maintains a quality management system certified to ISO 13485.